Why Did NuScale Power Stock Sink 18.8% This Week?

NuScale (NYSE: SMR) shares fell 18.8% this week, primarily due to significant selling by Fluor, one of its largest shareholders, which offloaded nearly $100 million in stock following a lock-up expiry. This initial sale is expected to be followed by further substantial divestments over the next two years, creating a potential supply overhang. The market is also considering NuScale's steep valuation and Goldman Sachs' recent neutral coverage initiation for competitor Oklo.

Analysis

NuScale Power's (NYSE: SMR) stock experienced a significant 18.8% decline, starkly underperforming the broader market, which saw only minor losses. The primary catalyst for this downward pressure is a material change in share liquidity and investor positioning following a major sale by Fluor, one of NuScale's largest and earliest investors. After the expiration of a 30-day lock-up period, Fluor sold nearly $100 million worth of its converted Class A common stock. Critically, the market is pricing in the expectation of a sustained supply overhang, as further sales amounting to potentially hundreds of millions of dollars are anticipated over the next two years. This technical pressure is compounded by fundamental valuation concerns, with the company's market capitalization exceeding $10 billion despite having 'extremely modest' revenue and its small modular reactor (SMR) technology being commercially unproven. The initiation of coverage on competitor Oklo by Goldman Sachs with a neutral rating also introduces a new competitive benchmark for investors to consider. While the long-term thematic narrative of a 'renaissance' in nuclear energy remains a potential tailwind, the immediate outlook is dominated by technical selling pressure and a demanding valuation.

Key Decisions for Investors

• Investors should anticipate continued share price volatility and downward pressure on SMR due to the significant and expected future stock sales from its major shareholder, Fluor.
• It is prudent to critically evaluate NuScale's high market capitalization relative to its pre-revenue status and unproven technology, as the current valuation may not adequately reflect the long road to profitability and inherent risks.
• For those with a high-risk tolerance aligned with the long-term nuclear energy theme, the current price weakness could be a point of interest, but monitoring the pace and volume of Fluor's divestment is essential before considering a new or adjusted position.